Package 71335-2229-1

{"route": ["ORAL"], "spl_id": "b182ebdb-eadd-4688-a71f-587fba8f1964", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["8c5d1f30-2d31-417d-860b-7228b7baaa64"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "35 TABLET in 1 BOTTLE, PLASTIC (71335-2229-1)", "package_ndc": "71335-2229-1", "marketing_start_date": "20240906"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (71335-2229-2)", "package_ndc": "71335-2229-2", "marketing_start_date": "20230823"}], "brand_name": "Acyclovir", "product_id": "71335-2229_b182ebdb-eadd-4688-a71f-587fba8f1964", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-2229", "generic_name": "Acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA075382", "marketing_category": "ANDA", "marketing_start_date": "20091022", "listing_expiration_date": "20261231"}